These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 23566552)

  • 21. Adult attention-deficit/hyperactivity disorder is associated with reduced norepinephrine transporter availability in right attention networks: a (S,S)-O-[
    Ulke C; Rullmann M; Huang J; Luthardt J; Becker GA; Patt M; Meyer PM; Tiepolt S; Hesse S; Sabri O; Strauß M
    Transl Psychiatry; 2019 Nov; 9(1):301. PubMed ID: 31732713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantification of serotonin transporter availability with [11C]MADAM--a comparison between the ECAT HRRT and HR systems.
    Schain M; Tóth M; Cselényi Z; Stenkrona P; Halldin C; Farde L; Varrone A
    Neuroimage; 2012 Mar; 60(1):800-7. PubMed ID: 22227138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain serotonin transporter binding in non-depressed patients with Parkinson's disease.
    Guttman M; Boileau I; Warsh J; Saint-Cyr JA; Ginovart N; McCluskey T; Houle S; Wilson A; Mundo E; Rusjan P; Meyer J; Kish SJ
    Eur J Neurol; 2007 May; 14(5):523-8. PubMed ID: 17437611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human serotonin transporter availability predicts fear conditioning.
    Åhs F; Frick A; Furmark T; Fredrikson M
    Int J Psychophysiol; 2015 Dec; 98(3 Pt 2):515-9. PubMed ID: 25498766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Occupancy of serotonin and norepinephrine transporter by milnacipran in patients with major depressive disorder: a positron emission tomography study with [(11)C]DASB and (S,S)-[(18)F]FMeNER-D(2).
    Nogami T; Takano H; Arakawa R; Ichimiya T; Fujiwara H; Kimura Y; Kodaka F; Sasaki T; Takahata K; Suzuki M; Nagashima T; Mori T; Shimada H; Fukuda H; Sekine M; Tateno A; Takahashi H; Ito H; Okubo Y; Suhara T
    Int J Neuropsychopharmacol; 2013 Jun; 16(5):937-43. PubMed ID: 23067569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect on [11C]DASB binding after tranylcypromine-induced increase in serotonin concentration: positron emission tomography studies in monkeys and rats.
    Lundquist P; Roman M; Syvänen S; Hartvig P; Blomquist G; Hammarlund-Udenaes M; Långström B
    Synapse; 2007 Jun; 61(6):440-9. PubMed ID: 17372973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regional Differences in Serotonin Transporter Occupancy by Escitalopram: An [
    Kim E; Howes OD; Kim BH; Chon MW; Seo S; Turkheimer FE; Lee JS; Lee YS; Kwon JS
    Clin Pharmacokinet; 2017 Apr; 56(4):371-381. PubMed ID: 27557550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ecstasy-induced reduction of the availability of the brain serotonin transporter as revealed by [11C](+)McN5652-PET and the multi-linear reference tissue model: loss of transporters or artifact of tracer kinetic modelling?
    Buchert R; Thiele F; Thomasius R; Wilke F; Petersen K; Brenner W; Mester J; Spies L; Clausen M
    J Psychopharmacol; 2007 Aug; 21(6):628-34. PubMed ID: 17092972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological characterization of N,N-dimethyl-2-(2-amino-4-methylphenyl thio)benzylamine as a ligand of the serotonin transporter with high affinity and selectivity.
    Chalon S; Tarkiainen J; Garreau L; Hall H; Emond P; Vercouillie J; Farde L; Dasse P; Varnas K; Besnard JC; Halldin C; Guilloteau D
    J Pharmacol Exp Ther; 2003 Jan; 304(1):81-7. PubMed ID: 12490578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suicidal ideation modulates the reduction in serotonin transporter availability in male military conscripts with major depression: A 4-[18F]-ADAM PET study.
    Yeh YW; Ho PS; Chen CY; Kuo SC; Liang CS; Yen CH; Huang CC; Shiue CY; Huang WS; Ma KH; Lu RB; Huang SY
    World J Biol Psychiatry; 2015 Oct; 16(7):502-12. PubMed ID: 26068129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The norepinephrine transporter in attention-deficit/hyperactivity disorder investigated with positron emission tomography.
    Vanicek T; Spies M; Rami-Mark C; Savli M; Höflich A; Kranz GS; Hahn A; Kutzelnigg A; Traub-Weidinger T; Mitterhauser M; Wadsak W; Hacker M; Volkow ND; Kasper S; Lanzenberger R
    JAMA Psychiatry; 2014 Dec; 71(12):1340-1349. PubMed ID: 25338091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serotonin transporter occupancy with TCAs and SSRIs: a PET study in patients with major depressive disorder.
    Lundberg J; Tiger M; Landén M; Halldin C; Farde L
    Int J Neuropsychopharmacol; 2012 Sep; 15(8):1167-72. PubMed ID: 22243688
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of tryptophan depletion on the serotonin transporter in healthy humans.
    Praschak-Rieder N; Wilson AA; Hussey D; Carella A; Wei C; Ginovart N; Schwarz MJ; Zach J; Houle S; Meyer JH
    Biol Psychiatry; 2005 Nov; 58(10):825-30. PubMed ID: 16026765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serotonin transporter binding in the hypothalamus correlates negatively with tonic heat pain ratings in healthy subjects: a [11C]DASB PET study.
    Kupers R; Frokjaer VG; Erritzoe D; Naert A; Budtz-Joergensen E; Nielsen FA; Kehlet H; Knudsen GM
    Neuroimage; 2011 Jan; 54(2):1336-43. PubMed ID: 20851771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and in vivo evaluation of halogenated N,N-dimethyl-2-(2'-amino-4'-hydroxymethylphenylthio)benzylamine derivatives as PET serotonin transporter ligands.
    Jarkas N; Voll RJ; Williams L; Votaw JR; Owens M; Goodman MM
    J Med Chem; 2008 Jan; 51(2):271-81. PubMed ID: 18085744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serotonin transporter availability in patients with schizophrenia: a positron emission tomography imaging study with [11C]DASB.
    Frankle WG; Narendran R; Huang Y; Hwang DR; Lombardo I; Cangiano C; Gil R; Laruelle M; Abi-Dargham A
    Biol Psychiatry; 2005 Jun; 57(12):1510-6. PubMed ID: 15953487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebral serotonin transporter binding is inversely related to body mass index.
    Erritzoe D; Frokjaer VG; Haahr MT; Kalbitzer J; Svarer C; Holst KK; Hansen DL; Jernigan TL; Lehel S; Knudsen GM
    Neuroimage; 2010 Aug; 52(1):284-9. PubMed ID: 20382236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of reduced endogenous 5-HT on the in vivo binding of the serotonin transporter radioligand 11C-DASB in healthy humans.
    Talbot PS; Frankle WG; Hwang DR; Huang Y; Suckow RF; Slifstein M; Abi-Dargham A; Laruelle M
    Synapse; 2005 Mar; 55(3):164-75. PubMed ID: 15605360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of estrogen and testosterone treatment on serotonin transporter binding in the brain of surgically postmenopausal women--a PET study.
    Jovanovic H; Kocoska-Maras L; Rådestad AF; Halldin C; Borg J; Hirschberg AL; Nordström AL
    Neuroimage; 2015 Feb; 106():47-54. PubMed ID: 25462800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is correction for age necessary in SPECT or PET of the central serotonin transporter in young, healthy adults?
    Buchert R; Schulze O; Wilke F; Berding G; Thomasius R; Petersen K; Brenner W; Clausen M
    J Nucl Med; 2006 Jan; 47(1):38-42. PubMed ID: 16391185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.